Neurotoxicity of MDMA: Main effects and mechanisms
- PMID: 34655576
- DOI: 10.1016/j.expneurol.2021.113894
Neurotoxicity of MDMA: Main effects and mechanisms
Abstract
Preclinical and clinical studies indicate that 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy'), in addition to having abuse potential, may elicit acute and persistent abnormalities of varying severity at the central level. Importantly, neurotoxic effects of MDMA have been demonstrated in experimental animals. Accordingly, central toxicity induced by MDMA may pose a serious harm for health, since MDMA is among the substances that are used for recreational purposes by young and adult people. This review provides a concise overview of recent findings from preclinical and clinical studies that evaluated the central effects of MDMA, and the mechanisms involved in the neurotoxicity induced by this amphetamine-related drug.
Keywords: Ecstasy; Excitotoxicity; Hyperthermia; MDMA metabolites; Mitochondrial dysfunction; Neuroinflammation; Neurotoxicity; Oxidative stress.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans.Br J Pharmacol. 2012 Jul;166(5):1523-36. doi: 10.1111/j.1476-5381.2011.01819.x. Br J Pharmacol. 2012. PMID: 22188379 Free PMC article. Review.
-
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms.Prog Neurobiol. 2017 Aug;155:149-170. doi: 10.1016/j.pneurobio.2015.09.011. Epub 2015 Oct 9. Prog Neurobiol. 2017. PMID: 26455459 Review.
-
A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response.Eur J Pharmacol. 2004 Oct 1;500(1-3):3-13. doi: 10.1016/j.ejphar.2004.07.006. Eur J Pharmacol. 2004. PMID: 15464016 Review.
-
The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity.Ther Drug Monit. 2004 Apr;26(2):132-6. doi: 10.1097/00007691-200404000-00008. Ther Drug Monit. 2004. PMID: 15228153 Review.
-
Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review.Curr Drug Abuse Rev. 2015;8(1):15-25. doi: 10.2174/1874473708666150303115833. Curr Drug Abuse Rev. 2015. PMID: 25731754 Review.
Cited by
-
Examining the Role of Oxytocinergic Signaling and Neuroinflammatory Markers in the Therapeutic Effects of MDMA in a Rat Model for PTSD.Pharmaceuticals (Basel). 2024 Jun 27;17(7):846. doi: 10.3390/ph17070846. Pharmaceuticals (Basel). 2024. PMID: 39065697 Free PMC article.
-
The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns.Arch Toxicol. 2024 Aug;98(8):2409-2427. doi: 10.1007/s00204-024-03765-8. Epub 2024 May 14. Arch Toxicol. 2024. PMID: 38743292 Review.
-
Characterization of the Neurochemical and Behavioral Effects of the Phenethylamine 2-Cl-4,5-MDMA in Adolescent and Adult Male Rats.Int J Neuropsychopharmacol. 2024 May 1;27(5):pyae016. doi: 10.1093/ijnp/pyae016. Int J Neuropsychopharmacol. 2024. PMID: 38546531 Free PMC article.
-
Brain dysfunctions and neurotoxicity induced by psychostimulants in experimental models and humans: an overview of recent findings.Neural Regen Res. 2024 Sep 1;19(9):1908-1918. doi: 10.4103/1673-5374.390971. Epub 2023 Dec 15. Neural Regen Res. 2024. PMID: 38227515 Free PMC article.
-
MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations.Eur Child Adolesc Psychiatry. 2023 Oct 10. doi: 10.1007/s00787-023-02310-9. Online ahead of print. Eur Child Adolesc Psychiatry. 2023. PMID: 37814082 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
